References

APA., 2013. Diagnostic and Statistical Manual of Mental Disorders. 5th Edn., American Psychiatric Association, USA., ISBN-13: 9780890425572, Pages: 991.

Beal, J.E., R. Olson, L. Laubenstein, J.O. Morales and P. Bellman et al., 1995. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Symptom Manag., 10: 89-97.
CrossRef  |  PubMed  |  Direct Link  |  

Beinfeld, M.C. and K. Connolly, 2001. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett., 301: 69-71.
CrossRef  |  PubMed  |  Direct Link  |  

Bermudez-Silva, F.J., M.P. Viveros, J.M. McPartland and F.R. De Fonseca, 2010. The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?. Pharmacol. Biochem. Behav., 95: 375-382.
CrossRef  |  Direct Link  |  

Bermudez-Silva, F.J., P. Cardinal and D. Cota, 2012. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J. Psychopharmacol., 26: 114-124.
CrossRef  |  PubMed  |  Direct Link  |  

Berridge, K.C., 1996. Food reward: Brain substrates of wanting and liking. Neurosci. Biobehav. Rev., 20: 1-25.
CrossRef  |  PubMed  |  Direct Link  |  

Bisogno, T., F. Berrendero, G. Ambrosino, M. Cebeira and J.A. Ramos et al., 1999. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun., 256: 377-380.
CrossRef  |  PubMed  |  Direct Link  |  

Boraska, V., C.S. Franklin, J.A. Floyd, L.M. Thornton and L.M. Huckins et al., 2014. A genome-wide association study of anorexia nervosa. Mol. Psychiatry, 19: 1085-1094.
CrossRef  |  PubMed  |  Direct Link  |  

Breivogel, C.S. and S.R. Childers, 1998. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol. Dis., 5: 417-431.
CrossRef  |  PubMed  |  Direct Link  |  

Brown, J.E., M. Kassouny and J.K. Cross, 1977. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ⁹-tetrahydrocannabinol. Behav. Biol., 20: 104-110.
CrossRef  |  PubMed  |  Direct Link  |  

Bulik, C.M., J. Hebebrand, A. Keski‐Rahkonen, K.L. Klump and T. Reichborn‐Kjennerud et al., 2007. Genetic epidemiology, endophenotypes and eating disorder classification. Intl. J. Eating Disord., 40: S52-S60.
CrossRef  |  PubMed  |  Direct Link  |  

Capasso, A., C. Petrella and W. Milano, 2009. Recent clinical aspects of eating disorders. Rev. Recent Clin. Trials, 4: 63-69.
Direct Link  |  

Carlim, E.A. and C. Kramer, 1965. Effects of Cannabis sativa (marihuana) on maze performance of the rat. Psychopharmacol., 7: 175-181.
CrossRef  |  PubMed  |  Direct Link  |  

Cassin, S.E. and K.M. Von Ranson, 2005. Personality and eating disorders: A decade in review. Clin. Psychol. Rev., 25: 895-916.
CrossRef  |  PubMed  |  Direct Link  |  

Chaperon, F. and M.H. Thiebot, 1999. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol., 13: 243-281.
CrossRef  |  PubMed  |  Direct Link  |  

Chesney, E., G.M. Goodwin and S. Fazel, 2014. Risks of all‐cause and suicide mortality in mental disorders: A meta‐review. World Psychiatry, 13: 153-160.
CrossRef  |  PubMed  |  Direct Link  |  

Cooper, S.J. and T.C. Kirkham, 1993. Opioid Mechanisms in the Control of Food Consumption and Taste Preferences. In: Opioids II: Handbook of Experimental Pharmacology, Herz, A., H. Akil and E.J. Simon (Eds.). Springer, Berlin, Heidelberg, Germany, ISBN:978-3-642-77542-0, pp: 239-262.

Cota, D., G. Marsicano, B. Lutz, V. Vicennati and G.K. Stalla et al., 2003. Endogenous cannabinoid system as a modulator of food intake. Intl. J. Obesity, 27: 289-301.
CrossRef  |  PubMed  |  Direct Link  |  

Crawley, J.N. and R.L. Corwin, 1994. Biological actions of cholecystokinin. Pept., 15: 731-755.
CrossRef  |  PubMed  |  Direct Link  |  

Culbert, K.M., S.E. Racine and K.L. Klump, 2015. Research review: What we have learned about the causes of eating disorders-a synthesis of sociocultural, psychological and biological research. J. Child Psychol. Psychiatry, 56: 1141-1164.
CrossRef  |  PubMed  |  Direct Link  |  

Culbert, K.M., S.E. Racine and K.L. Klump, 2016. Hormonal factors and disturbances in eating disorders. Curr. Psychiatry Rep., Vol. 18, 10.1007/s11920-016-0701-6

De Fonseca, F.R., M. Navarro, R. Gomez, L. Escuredo and F. Nava et al., 2001. An anorexic lipid mediator regulated by feeding. Nature, 414: 209-212.
CrossRef  |  Direct Link  |  

Dewey, W.L., L.S. Harris and J.S. Kennedy, 1972. Some pharmacological and toxicological effects of 1-trans-8 and 1-trans-9-tetrahydrocannabinol in laboratory rodents. Arch. Intl. Pharmacol. Ther., 196: 133-145.
PubMed  |  Direct Link  |  

Di Marzo, V. and S. Petrosino, 2007. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidology, 18: 129-140.
CrossRef  |  PubMed  |  Direct Link  |  

Di-Marzo, V., F. Berrendero, T. Bisogno, S. Gonzalez and P. Cavaliere et al., 2000. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9‐tetrahydrocannabinol‐tolerant rats. J. Neurochem., 74: 1627-1635.
CrossRef  |  PubMed  |  Direct Link  |  

Easter, M.M., 2012. Not all my fault: Genetics, stigma and personal responsibility for women with eating disorders. Soc. Sci. Med., 75: 1408-1416.
CrossRef  |  PubMed  |  Direct Link  |  

Erickson, J.C., K.E. Clegg and R.D. Palmiter, 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nat., 381: 415-418.
CrossRef  |  PubMed  |  Direct Link  |  

Favaro, C., A.E. Tenconi and P. Santonastaso, 2006. Perinatal factors and the risk of developing anorexia nervosa and bulimia nervosa. Arch. Gen. Psychiatry, 63: 82-88.
PubMed  |  

Fernandes, M., A. Schabarek, H. Coper and R. Hill, 1974. Modification of Δ⁹-THC-actions by cannabinol and cannabidiol in the rat. Psychopharmacol., 38: 329-338.
CrossRef  |  Direct Link  |  

Frieling, H., H. Albrecht, S. Jedtberg, A. Gozner and B. Lenz et al., 2009. Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders. Psychoneuroendocrinology, 34: 620-624.
CrossRef  |  PubMed  |  Direct Link  |  

Fu, J., S. Gaetani, F. Oveisi, J.L. Verme and A. Serrano et al., 2003. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nat., 425: 90-93.
CrossRef  |  PubMed  |  Direct Link  |  

Gaetani, S., W.H. Kaye, V. Cuomo and D. Piomelli, 2008. Role of endocannabinoids and their analogues in obesity and eating disorders. Eating Weight Disord. EWD., 13: 42-48.
PubMed  |  Direct Link  |  

Gallate, J.E., T. Saharov, P.E. Mallet and I.S. McGregor, 1999. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur. J. Pharmacol., 370: 233-240.
CrossRef  |  PubMed  |  Direct Link  |  

Gardner, E.L. and S.R. Vorel, 1998. Cannabinoid transmission and reward-related events. Neurobiol. Dis., 5: 502-533.
CrossRef  |  PubMed  |  Direct Link  |  

Giuliano, C. and P. Cottone, 2015. The role of the opioid system in binge eating disorder. CNS. Spectrums, 20: 537-545.
CrossRef  |  PubMed  |  Direct Link  |  

Glass, M., R.L.M Faull and M. Dragunow, 1997. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77: 299-318.
CrossRef  |  

Gross, H., M.H. Ebert, V.B. Faden, S.C. Goldberg and W.H. Kaye et al., 1983. A double-blind trial of Δ9-tetrahydrocannabinol in primary anorexia nervosa. J. Clin. Psychopharmacol., 3: 165-171.
PubMed  |  Direct Link  |  

Halmi, K.A., 2009. Salient components of a comprehensive service for eating disorders. World Psychiatry, 8: 150-155.
CrossRef  |  PubMed  |  Direct Link  |  

Halmi, K.A., 2013. Perplexities of treatment resistence in eating disorders. BMC. Psychiatry, 13: 1-6.
CrossRef  |  PubMed  |  Direct Link  |  

Hay, P., D. Chinn, D. Forbes, S. Madden and R. Newton et al., 2014. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. Aust. N.Z. J. Psychiatry, 48: 977-1008.
CrossRef  |  PubMed  |  Direct Link  |  

Hermann, H., G. Marsicano and B. Lutz, 2002. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neurosci., 109: 451-460.
CrossRef  |  PubMed  |  Direct Link  |  

Hirschberg, A.L., 2012. Sex hormones, appetite and eating behaviour in women. Maturitas, 71: 248-256.
CrossRef  |  PubMed  |  Direct Link  |  

Hoebel, B.G., 1985. Brain neurotransmitters in food and drug reward. Am. J. Clin. Nut., 42: 1133-1150.
CrossRef  |  PubMed  |  Direct Link  |  

Holtkamp, K., B. Herpertz-Dahlmann, K. Hebebrand, C. Mika and J. Kratzsch et al., 2006. Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol. Psychiatry, 60: 311-313.
CrossRef  |  PubMed  |  Direct Link  |  

Hudson, J.I., E. Hiripi, H.G. Pope Jr. and R.C. Kessier, 2007. The prevalence and correlates of eating disorders in the national comorbidity surey replication. Biol. Psychiatry, 61: 348-358.
CrossRef  |  PubMed  |  Direct Link  |  

Ishiguro, H., O. Carpio, Y. Horiuchi, A. Shu and S. Higuchi et al., 2010. A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands. Synapse, 64: 92-96.
CrossRef  |  PubMed  |  Direct Link  |  

Kaye, W., 2008. Neurobiology of anorexia and bulimia nervosa. Physiol. Behav., 94: 121-135.
CrossRef  |  PubMed  |  Direct Link  |  

Kaye, W., M. Strober and D. Jimerson, 2004. The Neurobiology of Eating Disorders. In: The Neurobiology of Mental Illness, Charney, D.S. and E.J. Nestler (Eds.). Oxford Press, New York, USA., pp: 111-228.

Kaye, W.H., A. Wagner, J.L. Fudge and M. Paulus, 2010. Neurocircuity of eating disorders. Behav. Neurobio. Eating Disord., 6: 37-57.
CrossRef  |  PubMed  |  Direct Link  |  

Keski-Rahkonen, A. and L. Mustelin, 2016. Epidemiology of eating disorders in Europe: Prevalence, incidence, comorbidity, course, consequences and risk factors. Curr. Opin. Psychiatry, 29: 340-345.
CrossRef  |  PubMed  |  Direct Link  |  

Kirkham, T.C. and C.M. Williams, 2011. Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacol., 153: 267-270.
CrossRef  |  PubMed  |  Direct Link  |  

Klein, T.W., 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Rev. Immunol., 5: 400-411.
CrossRef  |  PubMed  |  Direct Link  |  

Kunos, G. and S. Btakai, 2001. Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice. Neurochem. Res., 26: 1015-1021.
CrossRef  |  PubMed  |  Direct Link  |  

Manning, F.J., J.H. Mcdonough, T.F. Elsmore, C. Saller and F.J. Sodetz, 1971. Inhibition of normal growth by chronic administration of Δ-9-tetrahydrocannabinol. Sci., 174: 424-426.
CrossRef  |  PubMed  |  Direct Link  |  

Marsicano, G. and B. Lutz, 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci., 11: 4213-4225.
CrossRef  |  PubMed  |  Direct Link  |  

Massimo, C., 2014. [Anorexia and Bulimie]. IL MULINO, New York, USA., ISBN:9788815252845, Pages: 134 (In Italian).

Matias, I. and V. Di Marzo, 2007. Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab., 18: 27-37.
CrossRef  |  Direct Link  |  

McLaughlin, C.L., C.A. Baile and P.E. Bender, 1979. Cannabinols and feeding in sheep. Psychopharmacol., 64: 321-323.
CrossRef  |  PubMed  |  Direct Link  |  

Mechoulam, R. and E. Fride, 2001. Physiology: A hunger for cannabinoids. Nat., 410: 763-765.
CrossRef  |  Direct Link  |  

Micali, N., B. De Stavola, G. Ploubidis, E. Simonoff and J. Treasure et al., 2015. Adolescent eating disorder behaviours and cognitions: Gender-specific effects of child, maternal and family risk factors. Br. J. Psychiatry, 207: 320-327.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, A.M., V. Di-Marzo, P. Monteleone, G.R. Dalle and T. Aveta et al., 2016. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. Eur. J. Nutr., 55: 1799-1805.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, P. and M. Maj, 2013. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: Beyond the homeostatic control of food intake. Psychoneuroendocrinology, 38: 312-330.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, P., A. Tortorella, V. Martiadis, C. Di Filippo and B. Canestrelli et al., 2008. The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Psychoneuroendocrinology, 33: 546-550.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, P., E. Castaldo and M. Maj, 2008. Neuroendocrine dysregulation of food intake in eating disorders. Regul. Pept., 149: 39-50.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, P., I. Matias, V. Martiadis, L. De Petrocellis and M. Maj et al., 2005. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacol., 30: 1216-1221.
CrossRef  |  PubMed  |  Direct Link  |  

Monteleone, P., M. Bifulco, C. Di Filippo, P. Gazzerro and B. Canestrelli et al., 2009. Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: Evidence for synergistic effects. Genes Brain Behav., 8: 728-732.
CrossRef  |  

Mu, C., Y. Yang and W. Zhu, 2016. Gut microbiota: The brain peacekeeper. Front. Microbiol., Vol. 7, 10.3389/fmicb.2016.00345 27014255

Muller, T.D., K. Reichwald, G. Bronner, J. Kirschner and T.T. Nguyen et al., 2008. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc. Psychiatry Mental Health, 2: 1-17.
CrossRef  |  PubMed  |  Direct Link  |  

Naruse, T., H. Amano and Y. Koizumi, 1991. Possible involvement of dopamine D‐1 and D‐2 receptors in diazepam‐induced hyperphagia in rats. Fundam. Clin. Pharmacol., 5: 677-693.
CrossRef  |  PubMed  |  Direct Link  |  

Navarro, M., M.R.A. Carrera, W. Fratta, O. Valverde and G. Cossu et al., 2001. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J. Neurosci., 21: 5344-5350.
CrossRef  |  PubMed  |  Direct Link  |  

Nelson, K., D. Walsh, P. Deeter and F. Sheehan, 1994. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J. Palliative Care, 10: 14-18.
PubMed  |  Direct Link  |  

Nizzoli, U., C. Colli and C. Covri, 2007. [DCA: Eating Behavior Disorders: Manual for Operators, Teachers, Parents]. Carocci Editore Spa, Rome, Italy, ISBN:9788874665327, Pages: 189 (In Italian).

Petra, A.I., S. Panagiotidou, E. Hatziagelaki, J.M. Stewart, P. Conti and T.C. Theoharides, 2015. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin. Therapeut., 37: 984-995.
CrossRef  |  Direct Link  |  

Phillips, M.L., W.C. Drevets, S.L. Rauch and R. Lane, 2003. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Bio. Psychiatry, 54: 504-514.
CrossRef  |  PubMed  |  Direct Link  |  

Roth, J., A.L. Szulc and A. Danoff, 2011. Energy, evolution and human diseases: An overview. Am. J. Clin. Nutr., 93: 875S-883S.
CrossRef  |  PubMed  |  Direct Link  |  

Rowland, N.E., M. Mukherjee and K. Robertson, 2001. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacol., 159: 111-116.
CrossRef  |  PubMed  |  Direct Link  |  

Scanelli, G., M. Gualandi, M. Simoni and E. Manzato, 2014. Somatic involvement assessed through a cumulative score of clinical severity in patients with eating disorders. Eating Weight Disord. Stud. Anorexia Bulimia Obesity, 19: 49-59.
CrossRef  |  PubMed  |  Direct Link  |  

Schwartz, M.W., S.C. Woods, D. Porte Jr., R.J. Seeley and D.G. Baskin, 2000. Central nervous system control of food intake. Nature, 404: 661-671.
PubMed  |  

Sharan, P. and A.S. Sundar, 2015. Eating disorders in women. Indian J. Psychiatry, 57: S286-S295.
CrossRef  |  PubMed  |  Direct Link  |  

Siegfried, Z., K. Kanyas, Y. Latzer, O. Karni and M. Bloch et al., 2004. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes. Am. J. Med. Genet. Part B Neuropsychiatr. Genet., 125: 126-130.
CrossRef  |  PubMed  |  Direct Link  |  

Sim, L.A., D.E. McAlpine, K.B. Grothe, S.M. Himes and R.G. Cockerill et al., 2010. Identification and treatment of eating disorders in the primary care setting. Mayo Clin. Proc., 85: 746-751.
CrossRef  |  PubMed  |  Direct Link  |  

Sjoden, P.O., T.U. Jarbe and B.G. Henriksson, 1973. Influence of tetrahydrocannabinols (Δ⁸-THC and Δ⁹-THC) on body weight, food and water intake in rats. Pharmacol. Biochem. Behav., 1: 395-399.
CrossRef  |  Direct Link  |  

Sofia, R.D. and H. Barry, 1974. Acute and chronic effects of Δ⁹-tetrahydrocannabinol on food intake by rats. Psychopharmacol., 39: 213-222.
CrossRef  |  PubMed  |  Direct Link  |  

Spanagel, R. and F. Weiss, 1999. The dopamine hypothesis of reward: Past and current status. Trends Neurosci., 22: 521-527.
CrossRef  |  PubMed  |  Direct Link  |  

Spanagel, R. and F. Weiss, 1999. The dopamine hypothesis of reward: Past and current status. Trends Neurosci., 22: 521-527.
CrossRef  |  PubMed  |  Direct Link  |  

Stoving, R.K., A. Andries, K. Brixen, A. Flyvbjerg and K. Horder et al., 2009. Leptin, ghrelin and endocannabinoids: Potential therapeutic targets in anorexia nervosa. J. Psychiatric Res., 43: 671-679.
CrossRef  |  PubMed  |  Direct Link  |  

Thompson, G.R., R.W. Fleischman, H. Rosenkrantz and M.C. Braude, 1974. Oral and intravenous toxicity of Δ⁹-tetrahydrocannabinol in rhesus monkeys. Toxicol. Appl. Pharmacol., 27: 648-665.
CrossRef  |  PubMed  |  Direct Link  |  

Tong, J. and D. Dalessio, 2011. Eating disorders and gastrointestinal peptides. Curr. Opin. Endocrinol. Diabetes Obesity, 18: 42-49.
CrossRef  |  PubMed  |  Direct Link  |  

Tortorella, A., F. Brambilla, M. Fabrazzo, U. Volpe and A.M. Monteleone et al., 2014. Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: A literature review. Eur. Eating Disord. Rev., 22: 307-320.
CrossRef  |  PubMed  |  Direct Link  |  

Treasure, J., A.M. Claudino, N. Zucker, 2010. Eating disorders. Lancet, 375: 583-593.
CrossRef  |  PubMed  |  Direct Link  |  

Val-Laillet, D., E. Aarts, B. Weber, M. Ferrari and V. Quaresima et al., 2015. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. NeuroImage Clin., 8: 1-31.
CrossRef  |  PubMed  |  Direct Link  |  

Van Den Broek, G.W., J. Robertson, D.A. Keim and C.A. Baile, 1979. Feeding and depression of abomasal secretion in sheep elicited by elfazepam and 9-aza-cannabinol. Pharmacol. Biochem. Behav., 11: 51-56.
CrossRef  |  PubMed  |  Direct Link  |  

Verty, A.N., M.J. Evetts, G.J. Crouch, I.S. McGregor and A. Stefanidis et al., 2011. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology, 36: 1349-1358.
CrossRef  |  PubMed  |  Direct Link  |  

Vickers, S.P., C.T. Dourish and G.A. Kennett, 2001. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacol., 41: 200-209.
CrossRef  |  PubMed  |  Direct Link  |  

Volpe, U., A. Tortorella, M. Manchia, A.M. Monteleone and U. Albert et al., 2016. Eating disorders: What age at onset?. Psychiatry Res., 238: 225-227.
CrossRef  |  Direct Link  |  

Wiesenfeld-Hallin, Z., L.G. de Arauja, P. Alster, X.J. Xu and T. Hokfelt, 1999. Cholecystokinin/opioid interactions. Brain Res., 848: 78-89.
CrossRef  |  PubMed  |  Direct Link  |  

Williams, C.M. and T.C. Kirkham, 2002. Reversal of Δ⁹-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol. Biochem. Behav., 71: 333-340.
CrossRef  |  PubMed  |  Direct Link  |  

Yilmaz, Z., J.A. Hardaway and C.M. Bulik, 2015. Genetics and epigenetics of eating disorders. Adv. Genomics Genetics, 5: 131-150.
CrossRef  |  PubMed  |  Direct Link  |